This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Commercial Printing Industry Outlook: Solid Prospects Ahead
by Payal Jalan
Increasing application areas and rising consumer sentiments are boosting demand for products and services offered by commercial printers. However, rapid growth of digital media is a concern.
Cimpress to Acquire BuildASign to Boost Signage Businesses
by Zacks Equity Research
Cimpress (CMPR) inks deal to acquire BuildASign, in a bid to fortify its existing businesses, including Print, Upload and Vistaprint.
Cimpress (CMPR) Displays Bright Prospects, Risks Remain
by Zacks Equity Research
Steady investments in new markets are likely to drive Cimpress' (CMPR) organic growth. Higher costs pose a concern.
Cimpress (CMPR) Down 2.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Must Hold on to Cimpress (CMPR) Stock Now
by Zacks Equity Research
Cimpress (CMPR) benefits from a diversified business structure, acquired assets and investments focused on developing growth opportunities. However, rising costs and high debts remain concerning.
New Strong Sell Stocks for August 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cimpress (CMPR) Loss Narrows in Q4 on Y/Y Sales Growth
by Zacks Equity Research
Cimpress' (CMPR) fourth-quarter fiscal 2018 loss narrows year over year on the back of solid organic sales growth and forex tailwinds.
Industrial Stock Earnings Slated for Aug 1: CMPR, BDC & More
by Zacks Equity Research
Strengthening global economy and expanding manufacturing sector in the U.S. should be conducive to growth for industrial companies.
Cimpress (CMPR) Down 2.3% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cimpress Aims to Mitigate Risks by Decentralizing Operations
by Zacks Equity Research
Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.
Apogee Rides on Growing Construction Market Amid Rising Cost
by Zacks Equity Research
Growing construction market and the focus on operational improvements, as well as the impact of the tax reform, are anticipated to drive Apogee???s (APOG) performance despite rising cost.
Emerson (EMR) to Distribute Dixell Products in United States
by Zacks Equity Research
Emerson Electric (EMR) announces the finalization of an agreement with Weiss Instruments to directly serve the customers of its Dixell brand.
Emerson's New Transmitter Simplifies Maintenance & Operation
by Zacks Equity Research
Emerson Electric (EMR) unveils the Rosemount 8712EM Wall Mount Magnetic Flow Meter Transmitter with powerful diagnostic capabilities and usability features.
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Forget Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We have figured out a proven strategy that says lucrative returns can also be earned from less-risky stocks if some other parameters are considered.
Eurozone Beats United States Again: 5 Hot Stock Picks
by Zacks Equity Research
5 Europe-based stocks to buy as the region scores decade-high growth rate in 2017.
Parker-Hannifin (PH) Introduces Low-Lead Solenoid Valves
by Zacks Equity Research
Parker-Hannifin (PH) launches a Low-Lead Brass body series of solenoid valves for beverage dispensing industry.
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
by Zacks Equity Research
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
3 Low-Beta Stocks to Ease Jitters From Market Volatility
by Zacks Equity Research
Our intense research has developed a strategy that allows investors to spend money on securities with lower risk and fetch attractive returns.
5 Must Buy Stocks After Volatility Explodes
by David Bartosiak
These five Zacks Rank #1 (Strong Buy) stocks are on sale after volatility exploded in the market.
Cimpress (CMPR) Jumps: Stock Rises 6.2%
by Zacks Equity Research
The shares of Cimpress (CMPR) rose 6.2% on Friday.
Cimpress (CMPR) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cimpress (CMPR) Q2 earnings decline due to significant rise in operating expenses despite top-line growth.
Industrial Stocks' Earnings on Jan 31: JCI, IR, AVY, CMPR
by Supriyo Bose
The Industrial Products sector appears to be quite strong. Let's take a sneak peek at four major Industrial stocks scheduled to report earnings tomorrow to see how things are shaping up for the upcoming results.
Cimpress Rides on Portfolio Restructuring, Risks Persist
by Zacks Equity Research
Cimpress' (CMPR) business is scalable and its web presence and online tools for customer use are well established, although foreign currency woes remain potential headwinds.
Bemis Rides on Restructuring Plan, Hurricane Effect a Woe
by Zacks Equity Research
Bemis' (BMS) restructuring plan will help align its manufacturing and administrative cost structures with current business environment. However, its results will be hurt by rising raw material prices.